Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, et al. N Engl J Med 2023 Mar 6. doi: 10.1056/NEJMoa2213558.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, et al. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med 2023 Mar 6. doi: 10.1056/NEJMoa2213558.
PMID: 36877098